Analyst Report: NOW
1. EXECUTIVE SUMMARY
ServiceNow fell 33.87% over the week to a $105.12 close on Friday October 30, from $158.96 on October 23, and almost all of the damage came in the session after third-quarter results. The company reported on October 28 after the close; on Thursday the stock fell 26.95% on volume of 76.4 million shares, and it slipped another 4.15% on Friday. The immediate trigger was guidance for fourth-quarter current remaining performance obligations (cRPO) growth of 18.5%, against 21% in the third quarter, together with adjusted EPS of $1.00 against a $1.02 forecast (CNBC). Revenue and subscription growth beat. Software investors are already anxious about AI disrupting subscription models, and the slower backlog guide landed on that fear. Analysts mostly kept Buy-equivalent ratings while trimming targets, and the consensus target of $154.26 (MarketBeat) sits well above the current price. The fundamental record is intact, but the market has reset the growth multiple and needs evidence in the January report before it reverses.
2. THE CATALYST
ServiceNow published Q3 FY2026 results on October 28 after the close (press release / 8-K). The stock closed that day at $150.13 and traded down 3.00% on 28.8 million shares, ahead of the release. The reaction came in the October 29 session.
| Metric | Reported | Comparison | Source |
|---|---|---|---|
| Subscription revenue | $3,988m, up 21% (20.5% constant currency) | Company said it beat the high end of guidance | Press release / 8-K |
| Total revenue | $4.107bn | $4.095bn expected | Trefis |
| Adjusted EPS | $1.00 | $1.02 forecast | CNBC |
| cRPO | $13.65bn, up 20.5% (21% constant currency) | Q4 guided to 18.5% growth | Press release; Trefis, Money Morning |
| Q4 subscription growth guide | 21.5% ex-FX | Full-year subscription revenue and FCF margin outlook raised | Trefis; press release |
Management said strong early renewals pulled some Q4 deals into Q3 (Trefis), which explains part of the lower Q4 backlog guide. CNBC said the results did little to overturn "SaaSpocalypse" fears, the concern that new AI capabilities will upend traditional software business models. Citi's Tyler Radke described the lack of upside as "a little bit uncharacteristic for ServiceNow standards" (CNBC). CNBC called Thursday the stock's worst day ever.
Friday's 4.15% decline came with broader tech weakness, as investors rotated into defensive parts of the market (CNN). The S&P 500 fell 1.82% that session.
Barron's and Bloomberg headlines, which the research could read only in part, attribute the fall to a key revenue measure falling short and to a sales outlook that revived AI fears.
3. COMPANY PROFILE
ServiceNow (Technology, Software - Application) sells cloud-based workflow software covering IT service management, IT operations, security operations, customer service, HR delivery, legal operations, field service and strategic portfolio management. Its competitors in the panel's Systems Software peer group include Microsoft, CrowdStrike, Palo Alto Networks, Twilio, Fortinet and Gen Digital. Market capitalisation is $109.11bn.
Other third-quarter figures from the company:
- Remaining performance obligations reached $29.7bn, up 22%.
- Customers above $5m in annual contract value (ACV) reached 680, up about 23%.
- There were 19 transactions above $5m in net new ACV, over 135% year-over-year growth (Business Wire).
- Net new AI average contract value rose 65% (CNBC), and the AI contract target rose to at least $1.7bn (Trefis).
CEO Bill McDermott called the quarter "the inflection point for ServiceNow as the Super Intelligence Control Tower" (8-K).
The company spent about $9.2bn on acquisitions in the first nine months of the year, including the cybersecurity firm Armis, and borrowed to pay for them (Benzinga). The 8-K balance sheet shows short-term debt of $2,086m against none a year earlier.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The reported numbers show 21% subscription growth, a raised full-year outlook and rising large-deal activity. A 26.95% one-day drop reflects a change in how investors price the stock's growth durability, since the reported quarter itself offered no deterioration. The forward P/E is 21.0 against a trailing 75.6, which shows how much earnings growth the market still assumes, while the share price has gone back to a level last seen around the 200-day average zone.
Competing explanations. The sources disagree on cause. Trefis calls most of the fall company-specific, citing the EPS miss and the backlog guide. CNBC, CNN and Chartmill stress AI-disruption fear. Money Morning describes a crowded, high-multiple stock that could not absorb a slightly slower backlog story. My inference is that the company-specific trigger and the sector fear reinforced each other: a 2.5-point step down in cRPO growth would have drawn a smaller reaction without the disruption thesis already weighing on software.
Comparable episodes. Trefis said the stock had not fallen this far in a single session in the prior 365 days, and its largest drop in that period was 17.7% on April 23, 2026. Benzinga described the October 29 decline as the steepest since the 2012 listing, with the two worst sessions both in 2026. The Q2 report on July 22 also showed a beat, with cRPO of $13.20bn, up 21% (8-K), and the sources found no comparable selloff then. The July setup lacked a guided deceleration in backlog growth. A Motley Fool piece reportedly says most earlier one-day plunges were followed by gains, but its body text was unreadable, so I place no weight on it.
Peer read-across. Peer moves over the same week were mixed.
| Peer | Weekly move |
|---|---|
| MSFT | -0.50% |
| CRWD | -2.77% |
| PANW | -3.86% |
| TWLO | -21.68% |
| FTNT | -24.40% |
| GEN | +17.08% |
Fortinet fell sharply on its own disappointing quarterly results (Yahoo Finance), and Twilio also fell heavily, so the weakness reached parts of the software group. The large caps (Microsoft, CrowdStrike, Palo Alto Networks) moved far less than ServiceNow.
Analyst reaction (all MarketBeat, October 29, unless noted).
| Firm | Rating | Target change |
|---|---|---|
| UBS | Neutral | $150 to $140 |
| Citigroup | Buy | $170 to $157 |
| BTIG | Buy | $170 to $150 |
| TD Cowen | Buy | $165 to $160 |
| Wells Fargo | Overweight | $190 to $175 |
| Oppenheimer | Outperform | $165 reiterated |
| Morgan Stanley (TipRanks) | Not stated | $180 to $160 |
| StoneX (TipRanks) | Not stated | $165 to $150 |
Mizuho also lowered its target (TipRanks). A KeyBanc $110 target appears in one list and is unverified. The consensus rating is "Moderate Buy" with an average target of $154.26 (MarketBeat), about 47% above Friday's close. Oppenheimer said AI momentum counters the disruption thesis but does not establish a clear path to organic reacceleration, and advised buying the dip (Yahoo Finance). A TheStreet headline reported a $3m share purchase by the CEO; I could not confirm the details.
Bull case. Subscription growth of 21%, a raised full-year outlook, 65% growth in net new AI contract value and a multiple of 21.0 times forward earnings leave room for a rerating if backlog growth holds near 20%.
Bear case. Radke said investors wanted "something a little bit sooner" and that the market may need to wait until next year to see the inflection (CNBC). Investors also questioned the lack of near-term payoff from the forward-deployed engineering team. Acquisition spending and new short-term debt add balance sheet weight while growth in the key backlog measure slows.
5. TECHNICAL SNAPSHOT
The $105.12 close is the lowest in the ten-session table, so the table offers no support level; Friday's intraday low of $103.51 is the nearest reference. The nearest resistance is Thursday's $109.67 close. The shares trade below the 200-day average of $114.99 and well below the 50-day average of $138.68, and they sit 29.4% above the April 10 52-week low of $81.24 and far under the October 30, 2025 high of $192.97. Thursday's volume of 76.4 million was more than five times the 50-day average of 14.8 million, and Friday's 35.2 million (2.37 times average) shows selling continued at an elevated pace, a pattern that fits forced repositioning more than a quiet drift.
6. RISK FACTORS
- Backlog trajectory. A fourth-quarter cRPO growth rate at or below the 18.5% guide would confirm the deceleration that triggered the selloff.
- AI disruption narrative. The software sector remains exposed to the fear that AI tools erode subscription models, and Chartmill reported the fear has spread across several industries.
- Leverage and integration. The Armis deal and other acquisitions of about $9.2bn were partly debt financed, and short-term debt stands at $2,086m.
- Market backdrop. CNN described a bruising month for AI stocks, and the S&P 500 fell 1.82% on Friday.
- Data caveats. Some analyst details are unconfirmed (RBC's cut is dated differently by two sources; the KeyBanc target is unverified).
- Next catalyst. Q4 FY2026 results are due on 2027-01-27, with consensus EPS of $1.07 and revenue of $4.37bn. Trefis names current backlog growth as the metric to watch.
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). The stock trades between Friday's $103.51 low and the $109.67 resistance, with volume still above average. Further analyst target cuts and tech-sector weakness would push the price toward the $81.24 52-week low. A defensible stabilisation would show lower volume and closes holding above $109.67.
Medium term (1-3 months). The $114.99 200-day average is the first area where recovery would meet supply. Evidence of net new AI contract growth, further insider buying if confirmed, and stability in the peer group would lift the shares. A further drop in peer software names or fresh AI-disruption headlines would hold the price down. The January 27 report is the decisive event.
Long-term thesis. The business metrics (21% subscription growth, $29.7bn in RPO, rising large-deal counts) are unchanged. What has changed is the market's willingness to pay for growth that guidance now shows slowing in backlog terms. The thesis holds while cRPO growth stays near 20% and AI contracts scale toward the $1.7bn target; a sustained drop in cRPO growth below the 18.5% guide would weaken it. This is analysis only, not personal financial advice.